Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Metlife Inc (NYSE: MET) closed at $80.3 in the last session, down -0.93% from day before closing price of $81.05. In other words, the price has decreased by -$0.93 from its previous closing price. On the day, 1.61 million shares were traded. MET stock price reached its highest trading level at $80.9 during the session, while it also had its lowest trading level at $80.15.
Ratios:
We take a closer look at MET’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.69.
Upgrades & Downgrades
In the most recent recommendation for this company, Mizuho on December 16, 2025, initiated with a Outperform rating and assigned the stock a target price of $101. On September 19, 2025, Piper Sandler Downgraded its rating to Neutral which previously was Overweight but kept the price unchanged to $84. On September 16, 2025, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $95.Wolfe Research initiated its Outperform rating on September 16, 2025, with a $95 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 19 ’25 when Russell 1000 Value MetLife 401 bought 68 shares for $81.71 per share.
Metlife 401(k) Plan Large cap bought 359 shares of MET for $29,334 on Dec 19 ’25. On Dec 19 ’25, another insider, Separate Account II, who serves as the Affiliate of the company, bought 38 shares for $81.71 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MET now has a Market Capitalization of 53401591808 and an Enterprise Value of 71849000960. As of this moment, Metlife’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.12, and their Forward P/E ratio for the next fiscal year is 8.04. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.72. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.74 while its Price-to-Book (P/B) ratio in mrq is 1.83. Its current Enterprise Value per Revenue stands at 0.999 whereas that against EBITDA is 12.645.
Stock Price History:
The Beta on a monthly basis for MET is 0.76, which has changed by -0.014844775 over the last 52 weeks, in comparison to a change of 0.17318606 over the same period for the S&P500. Over the past 52 weeks, MET has reached a high of $88.09, while it has fallen to a 52-week low of $65.21. The 50-Day Moving Average of the stock is 2.25%, while the 200-Day Moving Average is calculated to be 2.21%.
Shares Statistics:
According to the various share statistics, MET traded on average about 3.42M shares per day over the past 3-months and 3744980 shares per day over the past 10 days. A total of 660.72M shares are outstanding, with a floating share count of 548.94M. Insiders hold about 16.69% of the company’s shares, while institutions hold 76.82% stake in the company. Shares short for MET as of 1765756800 were 8247239 with a Short Ratio of 2.41, compared to 1763078400 on 7686132. Therefore, it implies a Short% of Shares Outstanding of 8247239 and a Short% of Float of 1.50999995.
Dividends & Splits
The forward annual dividend rate for MET is 2.25, which was 2.225 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.027452188. The stock’s 5-year Average Dividend Yield is 2.98. The current Payout Ratio is 36.26% for MET, which recently paid a dividend on 2025-11-04 with an ex-dividend date of 2025-11-04. Stock splits for the company last occurred on 2017-08-07 when the company split stock in a 1122:1000 ratio.
Earnings Estimates
Investors are keenly observing as 14.0 analysts analyze and rate. The current performance of Metlife Inc (MET) in the stock market.The consensus estimate for the next quarter is $2.24, with high estimates of $2.38 and low estimates of $2.09.
Analysts are recommending an EPS of between $8.8 and $8.58 for the fiscal current year, implying an average EPS of $8.71. EPS for the following year is $9.99, with 15.0 analysts recommending between $10.2 and $9.45.
Revenue Estimates
According to 4 analysts,. The current quarter’s revenue is expected to be $31.44B. It ranges from a high estimate of $32.86B to a low estimate of $30.53B. As of. The current estimate, Metlife Inc’s year-ago sales were $19.74BFor the next quarter, 4 analysts are estimating revenue of $19.03B. There is a high estimate of $19.75B for the next quarter, whereas the lowest estimate is $18.44B.
A total of 6 analysts have provided revenue estimates for MET’s current fiscal year. The highest revenue estimate was $87.5B, while the lowest revenue estimate was $83.22B, resulting in an average revenue estimate of $85.34B. In the same quarter a year ago, actual revenue was $73.05BBased on 9 analysts’ estimates, the company’s revenue will be $78.13B in the next fiscal year. The high estimate is $81.51B and the low estimate is $74.66B.
